Tag: Carsten Brunn

FDA puts clinical hold on Selecta Biosciences SEL-302 phase 1/2 trial

pallavi123- November 27, 2021

Selecta Biosciences said that the US Food and Drug Administration (FDA) has imposed a clinical hold on its phase 1/2 clinical trial of SEL-302 gene ... Read More

Bayer hematology drug Jivi scores FDA approval for hemophilia A treatment

pharmanewsdaily- September 1, 2018

Jivi FDA approval : German pharma company Bayer has bagged the US Food and Drug Administration (FDA) approval for its recombinant factor VIII (rFVIII) replacement ... Read More